Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jark Böttcher

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2013
Structure-kinetic relationship study of CDK8/CycC specific compoundsElisabeth V Schneider, Jark Böttcher, Robert Huber, et al.
Journal of Molecular Biology|August 12, 2008
Structural and kinetic analysis of pyrrolidine-based inhibitors of the drug-resistant Ile84Val mutant of HIV-1 proteaseJark Böttcher, Andreas Blum, Andreas Heine, et al.
Archiv Der Pharmazie|July 5, 2007
Quinoline-based derivatives of pirinixic acid as dual PPAR alpha/gamma agonistsLaura Popescu, Oliver Rau, Jark Böttcher, et al.
Journal of Medicinal Chemistry|March 20, 2008
Structure-guided design of C2-symmetric HIV-1 protease inhibitors based on a pyrrolidine scaffoldAndreas Blum, Jark Böttcher, Andreas Heine, et al.
Chemmedchem|August 23, 2008
Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitorsJark Böttcher, Andreas Blum, Stefanie Dörr, et al.
Journal of Molecular Biology|July 19, 2011
Two solutions for the same problem: multiple binding modes of pyrrolidine-based HIV-1 protease inhibitorsAndreas Blum, Jark Böttcher, Stefanie Dörr, et al.
Methods in Enzymology|March 5, 2011
Key factors for successful generation of protein-fragment structures requirement on protein, crystals, and technologyJark Böttcher, Anja Jestel, Reiner Kiefersauer, et al.
Bioorganic & Medicinal Chemistry|September 2, 2008
Achiral oligoamines as versatile tool for the development of aspartic protease inhibitorsAndreas Blum, Jark Böttcher, Benedikt Sammet, et al.
Drug Discovery Today|August 23, 2024
Chemical coverage of human biological pathwaysHaejin Angela Kwak, Lihua Liu, Claudia Tredup, et al.
Mabs|September 26, 2015
Molecular basis of in vitro affinity maturation and functional evolution of a neutralizing anti-human GM-CSF antibodyRoy Eylenstein, Daniel Weinfurtner, Stefan Härtle, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2013
Structure-kinetic relationship study of CDK8/CycC specific compoundsElisabeth V Schneider, Jark Böttcher, Robert Huber, et al.
Journal of Molecular Biology|August 12, 2008
Structural and kinetic analysis of pyrrolidine-based inhibitors of the drug-resistant Ile84Val mutant of HIV-1 proteaseJark Böttcher, Andreas Blum, Andreas Heine, et al.
Archiv Der Pharmazie|July 5, 2007
Quinoline-based derivatives of pirinixic acid as dual PPAR alpha/gamma agonistsLaura Popescu, Oliver Rau, Jark Böttcher, et al.
Journal of Medicinal Chemistry|March 20, 2008
Structure-guided design of C2-symmetric HIV-1 protease inhibitors based on a pyrrolidine scaffoldAndreas Blum, Jark Böttcher, Andreas Heine, et al.
Chemmedchem|August 23, 2008
Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitorsJark Böttcher, Andreas Blum, Stefanie Dörr, et al.
Journal of Molecular Biology|July 19, 2011
Two solutions for the same problem: multiple binding modes of pyrrolidine-based HIV-1 protease inhibitorsAndreas Blum, Jark Böttcher, Stefanie Dörr, et al.
Methods in Enzymology|March 5, 2011
Key factors for successful generation of protein-fragment structures requirement on protein, crystals, and technologyJark Böttcher, Anja Jestel, Reiner Kiefersauer, et al.
Bioorganic & Medicinal Chemistry|September 2, 2008
Achiral oligoamines as versatile tool for the development of aspartic protease inhibitorsAndreas Blum, Jark Böttcher, Benedikt Sammet, et al.
Drug Discovery Today|August 23, 2024
Chemical coverage of human biological pathwaysHaejin Angela Kwak, Lihua Liu, Claudia Tredup, et al.
Mabs|September 26, 2015
Molecular basis of in vitro affinity maturation and functional evolution of a neutralizing anti-human GM-CSF antibodyRoy Eylenstein, Daniel Weinfurtner, Stefan Härtle, et al.
Pageof 4